Ladenburg Thalmann Financial Services’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $16K | Hold |
682
| – | – | ﹤0.01% | 4244 |
|
|
2019
Q3 | $12K | Hold |
682
| – | – | ﹤0.01% | 4294 |
|
|
2019
Q2 | $15K | Sell |
682
-500
| -42% | -$11K | ﹤0.01% | 4219 |
|
|
2019
Q1 | $25K | Hold |
1,182
| – | – | ﹤0.01% | 3849 |
|
|
2018
Q4 | $22K | Sell |
1,182
-100
| -8% | -$1.86K | ﹤0.01% | 3805 |
|
|
2018
Q3 | $31K | Buy |
1,282
+681
| +113% | +$16.5K | ﹤0.01% | 3625 |
|
|
2018
Q2 | $17K | Hold |
601
| – | – | ﹤0.01% | 3918 |
|
|
2018
Q1 | $17K | Buy |
601
+541
| +902% | +$15.3K | ﹤0.01% | 3918 |
|
|
2017
Q4 | $1K | Hold |
60
| – | – | ﹤0.01% | 4881 |
|
|
2017
Q3 | $2K | Hold |
60
| – | – | ﹤0.01% | 4651 |
|
|
2017
Q2 | $1K | Hold |
60
| – | – | ﹤0.01% | 4711 |
|
|
2017
Q1 | $1K | Hold |
60
| – | – | ﹤0.01% | 4686 |
|
|
2016
Q4 | $1K | Sell |
60
-1,000
| -94% | -$16.7K | ﹤0.01% | 4631 |
|
|
2016
Q3 | $27K | Buy |
1,060
+60
| +6% | +$1.53K | ﹤0.01% | 3196 |
|
|
2016
Q2 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 3246 |
|
|
2016
Q1 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 3184 |
|
|
2015
Q4 | $29K | Buy |
+1,000
| New | +$29K | ﹤0.01% | 2953 |
|